BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 28541641)

  • 1. Update on rare epithelial ovarian cancers: based on the Rare Ovarian Tumors Young Investigator Conference.
    Jang JYA; Yanaihara N; Pujade-Lauraine E; Mikami Y; Oda K; Bookman M; Ledermann J; Shimada M; Kiyokawa T; Kim BG; Matsumura N; Kaku T; Kuroda T; Nagayoshi Y; Kawabata A; Iida Y; Kim JW; Quinn M; Okamoto A
    J Gynecol Oncol; 2017 Jul; 28(4):e54. PubMed ID: 28541641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Rare ovarian tumours: therapeutic strategies in 2010, national website observatory for rare ovarian cancers and delineation of referent centers in France].
    Ray-Coquard I; Pautier P; Pujade-Lauraine E; Méeus P; Morice P; Treilleux I; Duvillard P; Alexandre J; Lhommé C; Selle F; Guastalla J
    Bull Cancer; 2010 Jan; 97(1):123-35. PubMed ID: 20007069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TP53 mutations are common in all subtypes of epithelial ovarian cancer and occur concomitantly with KRAS mutations in the mucinous type.
    Rechsteiner M; Zimmermann AK; Wild PJ; Caduff R; von Teichman A; Fink D; Moch H; Noske A
    Exp Mol Pathol; 2013 Oct; 95(2):235-41. PubMed ID: 23965232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oncologic outcome after recurrence in patients with stage I epithelial ovarian cancer: are clear-cell and mucinous histological types a different entities?
    Kajiyama H; Mizuno M; Shibata K; Umezu T; Suzuki S; Yamamoto E; Mitsui H; Sekiya R; Niimi K; Kawai M; Nagasaka T; Kikkawa F
    Eur J Obstet Gynecol Reprod Biol; 2014 Oct; 181():305-10. PubMed ID: 25203309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Fertility preservation, contraception and menopause hormone therapy in women treated for rare ovarian tumors: Guidelines from the French national network dedicated to rare gynaecological cancer].
    Rousset-Jablonski C; Selle F; Adda-Herzog E; Planchamp F; Selleret L; Pomel C; Chabbert-Buffet N; Daraï E; Pautier P; Trémollières F; Guyon F; Rouzier R; Laurence V; Chopin N; Faure-Conter C; Bentivegna E; Vacher-Lavenu MC; Lhomme C; Floquet A; Treilleux I; Lecuru F; Gouy S; Kalbacher E; Genestie C; de la Motte Rouge T; Ferron G; Devouassoux-Shisheboran M; Kurtz JE; Namer M; Joly F; Pujade-Lauraine E; Grynberg M; Querleu D; Morice P; Gompel A; Ray-Coquard I
    Bull Cancer; 2018 Mar; 105(3):299-314. PubMed ID: 29397916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-grade serous carcinoma: molecular features and contemporary treatment strategies.
    Angarita AM; Cholakian D; Fader AN
    Expert Rev Anticancer Ther; 2015; 15(8):893-9. PubMed ID: 26040191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The molecular biology of epithelial ovarian cancer].
    Leary A; Pautier P; Tazi Y; Morice P; Duvillard P; Gouy S; Uzan C; Gauthier H; Balleyguier C; Lhommé C
    Bull Cancer; 2012 Dec; 99(12):1161-73. PubMed ID: 23238064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Dualistic classification of epithelial ovarian cancer: Is it clinically relevant?].
    Devouassoux-Shisheboran M; Genestie C; Ray-Coquard I
    Bull Cancer; 2016 Mar; 103(3):252-8. PubMed ID: 26853278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancerous ovarian stem cells: obscure targets for therapy but relevant to chemoresistance.
    Ahmed N; Abubaker K; Findlay J; Quinn M
    J Cell Biochem; 2013 Jan; 114(1):21-34. PubMed ID: 22887554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Associations between residual disease and survival in epithelial ovarian cancer by histologic type.
    Melamed A; Manning-Geist B; Bregar AJ; Diver EJ; Goodman A; Del Carmen MG; Schorge JO; Rauh-Hain JA
    Gynecol Oncol; 2017 Nov; 147(2):250-256. PubMed ID: 28822556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early stage mucinous ovarian cancer: A review.
    Crane EK; Brown J
    Gynecol Oncol; 2018 Jun; 149(3):598-604. PubMed ID: 29429591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detailed overview on rare malignant ovarian tumors.
    Aust S; Eberst L; Tredan O; Rousset-Jablonski C; Treilleux I; Méeus P; Chopin N; Beurrier F; Charreton A; Véronique D; Hallouz A; Coulon A; Ricoeur A; Mastier C; Bouhamama A; Racadot S; Devouassoux-Shisheboran M; Haddad V; Ray-Coquard I
    Bull Cancer; 2020 Mar; 107(3):385-390. PubMed ID: 32115180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Statin treatment is associated with survival in a nationally representative population of elderly women with epithelial ovarian cancer.
    Vogel TJ; Goodman MT; Li AJ; Jeon CY
    Gynecol Oncol; 2017 Aug; 146(2):340-345. PubMed ID: 28596017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paradigm Shift in the Management Strategy for Epithelial Ovarian Cancer.
    Fujiwara K; McAlpine JN; Lheureux S; Matsumura N; Oza AM
    Am Soc Clin Oncol Educ Book; 2016; 35():e247-57. PubMed ID: 27249730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Morphologic, Immunophenotypic, and Molecular Features of Epithelial Ovarian Cancer.
    Ramalingam P
    Oncology (Williston Park); 2016 Feb; 30(2):166-76. PubMed ID: 26892153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic impact of concomitant p53 and PTEN on outcome in early stage (FIGO I-II) epithelial ovarian cancer.
    Skírnisdóttir I; Seidal T
    Int J Gynecol Cancer; 2011 Aug; 21(6):1024-31. PubMed ID: 21792012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endometriosis-associated Ovarian Cancers.
    Anglesio MS; Yong PJ
    Clin Obstet Gynecol; 2017 Dec; 60(4):711-727. PubMed ID: 28990985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A universal genetic testing initiative for patients with high-grade, non-mucinous epithelial ovarian cancer and the implications for cancer treatment.
    Bednar EM; Oakley HD; Sun CC; Burke CC; Munsell MF; Westin SN; Lu KH
    Gynecol Oncol; 2017 Aug; 146(2):399-404. PubMed ID: 28610746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Updates and emerging therapies for rare epithelial ovarian cancers: one size no longer fits all.
    Groen RS; Gershenson DM; Fader AN
    Gynecol Oncol; 2015 Feb; 136(2):373-83. PubMed ID: 25481800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rare epithelial tumors arising in or near the ovary: a review of the risk factors, presentation, and future treatment direction for ovarian clear cell and mucinous carcinoma.
    Jain A; Seiden MV
    Am Soc Clin Oncol Educ Book; 2013; ():. PubMed ID: 23714502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.